Improved proliferation of antigen-specific cytolytic T lymphocytes using a multimodal nanovaccine

References

• SchumacherTNSchreiberRDNeoantigens in cancer immunotherapyScience20153486230697425838375
   PubMed Web of Science ®Google Scholar
• SharmaPAllisonJPThe future of immune checkpoint therapyScience20153486230566125838373
   PubMed Web of Science ®Google Scholar
• AlbertMLSauterBBhardwajNDendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLsNature1998392667186899510252
   PubMed Web of Science ®Google Scholar
• BelloneMIezziGRoverePProcessing of engulfed apoptotic bodies yields T cell epitopesJ Immunol199715911539153999548479
   PubMed Web of Science ®Google Scholar
• MoodyDBBrikenVChengTYLipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentationNat Immunol20023543544211938350
   PubMedGoogle Scholar
• PhamWKobukaiSHottaCGoreJCDendritic cells: therapy and imagingExpert Opin Biol Ther20099553956419392575
   PubMed Web of Science ®Google Scholar
• CruzLJTackenPJRuedaFDomingoJCAlbericioFFigdorCGTargeting nanoparticles to dendritic cells for immunotherapyMethods Enzymol201250914316322568905
   PubMed Web of Science ®Google Scholar
• KobukaiSKremersGJCobbJGInduction of antitumor immunity by dendritic cells loaded with MPA11P-conjugated mucin-1 peptide antigenTransl Oncol2011411821286372
   PubMedGoogle Scholar
• ChenSNdhlovuLCTakahashiTCo-inhibitory roles for glucocorticoid-induced TNF receptor in CD1d-dependent natural killer T cellsEur J Immunol20083882229224018624295
   PubMedGoogle Scholar
• DidierlaurentAMCollignonCBourguignonPEnhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cellsJ Immunol201419341920193025024381
   PubMed Web of Science ®Google Scholar
• DupuisMMurphyTJHigginsDDendritic cells internalize vaccine adjuvant after intramuscular injectionCell Immunol1998186118279637761
   PubMed Web of Science ®Google Scholar
• GungorBYagciFCTincerGCpG ODN nanorings induce IFNalpha from plasmacytoid dendritic cells and demonstrate potent vaccine adjuvant activitySci Transl Med20146235235ra61
   PubMed Web of Science ®Google Scholar
• ShahJADarrahPAAmbrozakDRDendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in miceJ Exp Med2003198228129112874261
   PubMedGoogle Scholar
• BachmannMFJenningsGTVaccine delivery: a matter of size, geometry, kinetics and molecular patternsNat Rev Immunol2010101178779620948547
   PubMed Web of Science ®Google Scholar
• Macho-FernandezECruzLJGhinnagowRTargeted delivery of alpha-galactosylceramide to CD8alpha+ dendritic cells optimizes type I NKT cell-based antitumor responsesJ Immunol2014193296196924913977
   PubMedGoogle Scholar
• GoffRDGaoYMattnerJEffects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cellsJ Am Chem Soc200412642136021360315493902
   PubMedGoogle Scholar
• BendelacASavagePBTeytonLThe biology of NKT cellsAnnu Rev Immunol20072529733617150027
   PubMed Web of Science ®Google Scholar
• BaiLSagivYLiuYLysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen alphaGalCerProc Natl Acad Sci U S A200910625102541025919506241
   PubMedGoogle Scholar
• ChangDHOsmanKConnollyJSustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosylceramide loaded mature dendritic cells in cancer patientsJ Exp Med200520191503151715867097
   PubMed Web of Science ®Google Scholar
• ImJSAroraPBricardGKinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activationImmunity200930688889819538930
   PubMedGoogle Scholar
• KuniiNHoriguchiSMotohashiSCombination therapy of in vitro-expanded natural killer T cells and alpha-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinomaCancer Sci200910061092109819302288
   PubMedGoogle Scholar
• ZhuGMallerySRSchwendemanSPStabilization of proteins encapsulated in injectable poly(lactide-co-glycolide)Nat Biotechnol2000181525710625391
   PubMed Web of Science ®Google Scholar
• KirbyGTWhiteLJRahmanCVPLGA-based micropartilcles for the sustained release of BMP-2Polymers201131571586
   Google Scholar
• MoritaTHorikiriYSuzukiTYoshinoHApplicability of various amphiphilic polymers to the modification of protein release kinetics from biodegradable reservoir-type microspheresEur J Pharm Biopharm2001511455311154903
   PubMedGoogle Scholar
• KobukaiSBahezaRCobbJGMagnetic nanoparticles for imaging dendritic cellsMagn Reson Med20106351383139020432309
   PubMedGoogle Scholar
• TokiSOmaryRAWilsonKGoreJCPeeblesRSJrPhamWA comprehensive analysis of transfection-assisted delivery of iron oxide nanoparticles to dendritic cellsNanomedicine2013981235124423747738
   PubMedGoogle Scholar
• BadovinacVPHartyJTIntracellular staining for TNF and IFN-g detects different frequencies of antigen-specific CD8 T cellsJ Immunol Methods20002381–210711710758241
   PubMedGoogle Scholar
• PapadogiannakisEIKontosVITamamidouMRoumeliotouADetermination of intracellular cytokines IFN-gamma and IL-4 in canine T lymphocytes by flow cytometry following whole-blood cultureCan J Vet Res200973213714319436583
   PubMedGoogle Scholar
• TashiroTSekine-KondoEShigeuraTInduction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cellsInt Immunol201022431932820181652
   PubMedGoogle Scholar
• Van KaerLAlpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstaclesNat Rev Immunol200551314215630427
   PubMedGoogle Scholar
• ChangYJHuangJRTsaiYCPotent immune-modulating and anticancer effects of NKT cell stimulatory glycolipidsProc Natl Acad Sci U S A200710425102991030417566107
   PubMedGoogle Scholar
• ShimamotoMUenoYTanakaSSelective decrease in colonic CD56(+) T and CD161(+) T cells in the inflamed mucosa of patients with ulcerative colitisWorld J Gastroenterol200713455995600218023089
   PubMedGoogle Scholar
• YuJMitsuiTWeiMNKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and humanJ Clin Invest201112141456147021364281
   PubMed Web of Science ®Google Scholar
• CruzLJTackenPJFokkinkRTargeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitroJ Control Release2010144211812620156497
   PubMed Web of Science ®Google Scholar
• GhotbiZHaddadiAHamdySHungRWSamuelJLavasanifarAActive targeting of dendritic cells with mannan-decorated PLGA nanoparticlesJ Drug Target201119428129220590403
   PubMed Web of Science ®Google Scholar
• Waeckerle-MenYGroettrupMPLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccinesAdv Drug Deliv Rev200557347548215560953
   PubMed Web of Science ®Google Scholar
• FaisFMorabitoFStelitanoCCD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytesInt J Cancer2004109340241114961579
   PubMed Web of Science ®Google Scholar
• MetelitsaLSWeinbergKIEmanuelPDSeegerRCExpression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cellsLeukemia20031761068107712764370
   PubMed Web of Science ®Google Scholar
• ImJSTapinosNChaeGTExpression of CD1d molecules by human schwann cells and potential interactions with immunoregulatory invariant NKT cellsJ Immunol200617785226523517015708
   PubMedGoogle Scholar
• FurlanRBergamiACantarellaDActivation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gammaEur J Immunol20033371830183812811843
   PubMedGoogle Scholar
• IshikawaEMotohashiSIshikawaADendritic cell maturation by CD11c- T cells and Valpha24+ natural killer T-cell activation by alpha-galactosylceramideInt J Cancer2005117226527315900581
   PubMedGoogle Scholar
• LuXSongLMetelitsaLSBittmanRSynthesis and evaluation of an alpha-C-galactosylceramide analogue that induces Th1-biased responses in human natural killer T cellsChembiochem20067111750175617009272
   PubMedGoogle Scholar
• OrtaldoJRYoungHAWinkler-PickettRTBereEWJrMurphyWJWiltroutRHDissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramidesJ Immunol2004172294395314707067
   PubMedGoogle Scholar
• MoritaMMotokiKAkimotoKStructure-activity relationship of alpha-galactosylceramides against B16-bearing miceJ Med Chem19953812217621877783149
   PubMedGoogle Scholar
• BiburgerMTiegsGAlpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cellsJ Immunol200517531540155016034092
   PubMed Web of Science ®Google Scholar
• Gonzalez-JuarreroMOrmeIMCharacterization of murine lung dendritic cells infected with Mycobacterium tuberculosisInfect Immun20016921127113311160010
   PubMedGoogle Scholar
• Marchal-SommeJUzunhanYMarchand-AdamSDendritic cells accumulate in human fibrotic interstitial lung diseaseAm J Respir Crit Care Med2007176101007101417717200
   PubMedGoogle Scholar